NCT02166372Recruiting
Taiwan Diabesity Study:Comparison With Mild Obese T2DM Patients Who Under Metabolic Surgery
Source: ClinicalTrials.gov · Last updated 18 Jun 2014 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
T2DM has become a major health burden for our society. More and more data support the relative effectiveness of gastrointestinal metabolic surgery, known as bariatric surgery, in the remission of T2DM of BMI less35. The metabolic surgery guidelines of IDF recommend BMI over 27.5 in Asia. The evidence reviewed above strongly points to the need for a large randomized, controlled trial to evaluate the risks and benefits of obesity surgery in the treatment of type 2 diabetes Mellitus. This study is expected to provide very significant findings about the natural course of diabetes in obese diabetic patients.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 1000 (estimated)
- First submitted
- 16 Jun 2014
- Start date
- 1 Mar 2014
- Primary completion date
- 31 Dec 2024
- Lead sponsor
- Min-Sheng General Hospital
- Diseases
- Obesity
- NCT number
- NCT02166372
What you commit to
- Study type: Observational
- Planned participants: 1000
- From 1 Mar 2014 to the primary completion date, 31 Dec 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Diagnosed with cancer within past five years
- HIV positive
- Cushing's syndrome
- History of organ transplant
- History of bariatric surgery
- History of alcohol or drug dependency in past five years
Lab values
- serum cretinine over 2.0 mg/dl
Other
- Active TB patients
- CV events in past six months
- C-peptide bellow 1.0 ng/ml in past three months
- Diabetic retinopathy; vision bellow 0.1
- Psychological problems likely to interfere with adherence to protocol
Who the study is looking for
- Diabetic Mellitus Type 2 medically controlled at Diabetes Center for at least six months
- BMI over 25
- age between 20 and 67
Age in the registry: 20 years to 67 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Min-Sheng General Hospital Coordinator of this site? Confirm its status | Taoyuan City | Taiwan | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.